[Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor]
Journal article published in 1998 by
F. Turkstra 
,
M. Levi,
Koopman Mm,
Wester Jp,
Stoutenbeek Cp,
E. Briët
,
M. Levi,
Koopman Mm,
Wester Jp,
Stoutenbeek Cp,
E. Briët
